232
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Prevalence, awareness, characteristics, and health outcomes associated with COPD at-risk status among adults in Japan

, , &
 

Abstract

Objectives: We examined the prevalence of chronic obstructive pulmonary disease (COPD) diagnosed and at-risk status, and public awareness of COPD among adults in Japan, as well as respondent characteristics and health outcomes compared with controls. Methods: Regression models used 2012 National Health and Wellness Survey in Japan data to compare COPD-diagnosed, at-risk, and healthy adults (aged ≥18) on demographics, health behaviors, health-related quality of life (HRQoL), productivity and healthcare resource use. Results: Among n = 29,978 respondents, diagnosed COPD prevalence was 0.9%; 26.9% were at-risk. Relative to controls, those at-risk and diagnosed with COPD had significantly greater healthcare resource use, with lower productivity and HRQoL. Fewer than 20% of respondents were aware of COPD. Conclusions: Over 25% of adult Japanese respondents were at-risk for COPD and had health outcomes impairments relative to controls. Efforts to increase awareness among the general public are needed.

Acknowledgements

The authors would like to acknowledge the contribution of Martine Maculaitis, an independent research consultant, for literature review and editing on behalf of Kantar Health.

Financial & competing interests disclosure

GlaxoSmithKline (GSK) provided funding for this study. H Omori has received lecture fees from GSK. D Yoshimoto is an employee of GSK. A Goren is an employee of Kantar Health, which received funding from GSK for conducting and reporting on this study. M Kumar was an employee of Kantar Health at the time of this study. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.